– Zandelisib Demonstrated 70.3% Objective Response Rate; 35.2% Achieved Complete Response –
– 9.9% of Patients Discontinued Therapy Due to a Drug Related Adverse Event –
– MEI to Host Webcast Today at 8:00am Eastern Time –
MEI Pharma Conference Call and Webcast
MEI will host an investor and analyst webcast event today, November 30, 2021, at 8:00 AM Eastern Time to review the TIDAL phase 2 study data reported today and to provide a corporate overview.
You can access the live webcast with slides under the investor relations section of MEI's website on the "Events and Presentation" page at: www.meipharma.com. A replay of the webcast will be archived for at least 30 days after the conclusion of the live event.
To view additional media and investor resources from MEI Pharma click here.
https://finance.yahoo.com/news/mei-pharma-kyowa-kirin-announce-120000988.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.